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EXECUTIVE SUMMARY
The goal of the Innovative Prosecution Solutions for Combating Violent Crime
and Illegal Opioids (IPS) grant is to reduce opioid-related deaths by fostering
inter-agency collaboration to disrupt local opioid supply chains, educate the
community about the dangers of opioid abuse and addiction, and provide support
for individuals with opioid use disorder.
This report describes: 1) the history and
current state of the opioid crisis in East Baton
Rouge Parish; 2) the current and planned
efforts of the IPS grant to respond to the
crisis; and 3) recommendations for criminal
justice practitioners regarding the opioid
crisis in our community.
The rising prevalence of opioid-related is a
significant issue in East Baton Rouge Parish,
Louisiana. From 2014 to 2018:
• Opioid poisoning-related emergency
department visits increased by 45%,
•

•

Heroin poisoning-related emergency
department visits increased by 30%,
and
Non-heroin opioid poisoning-related
emergency department visits increased

by 59%.

As emergency department visits increased,
so did overdose deaths in East Baton Rouge
Parish:
• From 2018 to 2019, opioid overdose

deaths increased by 29%. Opioid

overdose deaths have consistently
accounted for nearly all overdose
deaths during this time frame.
•

From January to June 2020, opioid

overdose deaths increased by 113%

compared to the same months of 2019.
Early attempts to address the opioid crisis
were challenging due to a lack of trust
and cooperation among governmental
agencies and community members most
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affected by the opioid epidemic. Criminal
justice practitioners (e.g., law enforcement,
correctional officials, defense attorneys,
prosecutors, court officials) have an important
role in reducing opioid-related addiction,
overdose deaths, and violence within East
Baton Rouge Parish communities. Individuals
with substance use disorder are often fearful
of interacting with law enforcement due to
the belief that they will be arrested for their
addiction, decreasing the likelihood that
these individuals will reach out for critical
treatment. Therefore, public health officials
can be reluctant to include criminal justice
practitioners in opioid use disorder-related
efforts, despite their ability to engage in
meaningful, productive partnerships.

For these perceptions to change,
criminal justice practitioners must
demonstrate a commitment to
addiction and overdose prevention
by forming vital partnerships and
supporting their partners’ prevention
efforts to address this epidemic.
By engaging in meaningful community
partnerships, criminal justice practitioners can
implement and support efforts to improve the
lives of individuals with opioid use disorder
and reduce opioid overdose deaths. The
following recommendations were informed by
empirical research related to criminal justice
and public health interventions concerning
opioid use disorder. This report further details
each recommendation.

Social Research & Evaluation Center, Louisiana State University

RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE COMMUNITY

Strengthen
community
partnerships to expand
access points

Partner with public health and community organizations
to implement protocols which emphasize connecting
individuals with substance use disorders to viable treatment
programs and removing existing barriers to adequate
treatment and recovery.

Expand
prescription medication
disposal programs

Engage in community partnerships to expand prescription
medication disposal programs by permanently establishing
secure disposal sites for unused and expired medication
at law enforcement substations and other amenable
community locations.

Expand
community education
efforts

Support
the expansion of
effective treatment and
harm reduction efforts
Publicize
the Good
Samaritan Laws
Bolster
prevention efforts

Expand planned community education efforts, such as
push cards and community forums, to include information
about situation-specific support programs for survivors
(e.g., pregnancy-based treatment, neonatal treatment, safe
needle exchange sites).
Support harm reduction efforts, such as needle exchange
programs, Take Home Naloxone programs for hospitals,
fentanyl testing kits, as well as community-wide access to
evidence-based treatments such as medication-assisted
treatment (MAT) and peer-recovery programs.
Partner with public health and community organizations to
raise public awareness of the current Good Samaritan laws,
including situational limitations for immunity.
Develop cross sector partnerships to prevent the
development of substance misuse among youth and other
vulnerable populations through educational campaigns.

The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020
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RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE FIELD

Implement
departmental protocols
regarding possession
and use

Develop departmental protocols that emphasize
linking individuals to treatment and obtaining
cooperation, which would enhance the ability
to pursue those responsible for manufacturing,
supplying, and distributing illegal narcotics in the
community.

Continue leveraging federal law enforcement
Continue to utilize partnerships to access the investigatory and
prosecutorial resources available to East
federal law
Baton Rouge Parish as a High Intensity Drug
enforcement levers Trafficking Area (HIDTA) to pursue cases involving
manufacturers, suppliers, and distributors.

Identify and monitor Use data scraping techniques and social network
social networks using analysis to identify patterns of illicit drug sales
social media data occurring on public social media.
Develop
a forensic certificationbased Collegiate
Internship Program

Provide local college students with the necessary
training to receive a uniform forensic analyst
certification, as well as professional experience
utilizing this training within a Crime Strategies Unit
or local law enforcement agency.

Provide Refer potential participants to the District Attorney
appropriate referrals to for the 19th JDC Drug Court treatment and
drug court diversion program.
Distribute naloxone upon release to individuals
Establish who have a history of substance use disorder,
overdose, or charges pertaining to drug use,
a Prison Take Home
as well as provide training on proper naloxone
Naloxone Program administration, to reduce overdose deaths after
release.
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RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE FIELD

Collaborate with public health and community
organizations to establish a Leave Behind
Establish Naloxone Program. First responders should be
a Leave Behind prepared to leave naloxone with the survivor of
Naloxone Program an overdose or individuals in a position to assist
the survivor, as well as provide training on proper
naloxone administration.
Partner with public health officials to share relevant
Provide data about the location of overdoses and the
concentration of hotspots to inform the deployment
insight regarding
of resources (e.g., Louisiana State Opioid Response
overdose hotspots Medication-Assisted Treatment Mobile Unit) and
prevention specialists.

Implement
a Public Health and
Safety Team (PHAST)

Partner with public health and community
organizations to implement a Public Health and
Safety Team (PHAST) responsible for conducting
overdose fatality reviews.

The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020
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STATEMENT OF THE PROBLEM
The rising prevalence of opioid-related overdose deaths and opioid-related violence has
become a significant issue in East Baton Rouge Parish, Louisiana. Early attempts to address the
opioid crisis were a challenge for criminal justice practitioners. A lack of coordination among
governmental agencies, along with a lack of trust and cooperation among community members
most affected by the opioid epidemic, led to barriers in disrupting the illicit opioid drug market
through the investigation and prosecution of opioid suppliers. Education about opioid addiction
among law enforcement and community members was needed to foster an understanding that
opioid overdoses are not victim-less crimes to be dismissed.
To combat the opioid crisis, criminal justice practitioners recognized the need to use
empirical, evidence-based interventions to interrupt the opioid drug market and reduce violent
crime related to drug trafficking. The Innovative Prosecution Solutions for Combating Violent
Crime and Illegal Opioids (IPS) grant, led by the District Attorney Hillar C. Moore of the 19th
Judicial District, has proposed several interventions to reduce opioid-related deaths in East
Baton Rouge Parish.
This document describes the history and current state of the opioid crisis in East Baton
Rouge Parish, the current and planned efforts of the IPS grant to respond to the crisis, and
further recommendations that the criminal justice community might implement or support to
reduce opioid overdose deaths in our community.

Historical National Trends
Prescription Opioid Abuse
Opioid prescribing in the United States increased rapidly at the beginning of the
21st century due to decades of aggressive marketing tactics employed by pharmaceutical
corporations and the unproven yet widely-held assumptions in the medical community about
the effectiveness and safety of long-term opioid treatment to treat acute and chronic pain.1,
2, 3

From 1999 to 2008, opioid prescription sales in the United States increased by 400%,4
consumption of hydrocodone increased by over 200%, and consumption of oxycodone
increased by nearly 500%.3
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Because prescription opioids were easier to access, non-medical prescription opioid
abuse sharply increased throughout the late 1990s and early 2000s, peaking in 2002 with 2.7
million new non-medical users.3 As prescriptions of opioids increased, so did overdose deaths
from prescription opioids.1, 4 In 2008, prescription opioid-related overdose deaths in the U.S.
accounted for 73.8% of the 20,044 prescription drug overdose deaths and accounted for 40.6%
of the 36,450 overall drug overdose deaths.4
In 2010, legislators and public health officials responded to this alarming trend by
implementing a series of criminal justice and public health interventions, which worked to
reduce the rising prevalence of prescription opioid-related overdose deaths.1 An abusedeterrent formulation, which is more difficult to crush, inject, and inhale, replaced long-lasting
oxycodone;5, 6 propoxyphene was removed from the market;1 and prescription drug monitoring
programs were established to enhance accountability and promote safer prescription
practices.7, 8, 9 Legislators passed restrictions on high-volume opioid prescriptions within pain
management clinics, as well as requirements for medical examinations and follow-ups when
prescribing opioids for chronic pain.10, 11, 12, 13 Communities began to implement community
overdose education and naloxone rescue programs to reduce the prevalence of prescription
opioid-related overdose deaths. The expansion of these programs across the country led to the
near-ubiquitous nationwide adoption of legislation supporting naloxone provision to citizens by
2016.14

Heroin and Synthetic Opioids
Though efforts to reduce prescription opioid abuse throughout the 2010s exhibited a
certain degree of success, it was insufficient to prevent the catastrophic wave of substance
use disorder and addiction set into motion by the opioid prescribing practices of the previous
decade.1 The introduction of abuse-deterrent formulations ensured that users could not
circumvent the extended-release properties of prescription opioids to produce an intense shortterm high. At the same time, legislative reform efforts restricted access to previously obtainable
prescription opioids. While the newly adopted measures succeeded in reducing opioid access,
they often failed to address the widespread misuse of and addiction to these medications. 1, 6
Individuals with opioid use disorder transitioned to using a more readily available and cheaper
substitute: heroin. 5, 6, 15, 16 Thus, these measures unintentionally facilitated a national shift from
prescription opioid abuse to illicit opioid abuse.
Prior prescription opioid abuse among active heroin users has been well documented,
suggesting the overzealous opioid prescribing patterns of the 2000s and subsequent public
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health interventions had a direct influence on the exponential increase in heroin overdose
deaths.17, 18, 19, 20 From 2004 to 2010, the number of active heroin users who reported
prescription opioid abuse prior to heroin initiation increased from approximately 64% to 80%.17,
18, 19

Relative to the steady increase which occurred throughout the 2000s, heroin overdose
deaths increased by 500% throughout the 2010s, peaking in 2017 with 15,482 deaths.21, 22
The ever-increasing demand for heroin throughout the early 2010s severely impacted
existing illicit narcotic supply chains.20 A third opioid mortality wave rapidly emerged in 2013
with the introduction of illicitly manufactured synthetic opioids (e.g., fentanyl and fentanyl
analogs) as a means of adulterating heroin supply chains.20, 23, 24, 25 Featuring a similar potency
to fentanyl produced legally in commercial pharmaceutical laboratories, illicitly manufactured
fentanyl provided a cheap alternative that could be produced as a powder to supplement or
substitute for heroin to extend supplies, or as a tablet to mimic less potent opioids.26 With a
potency 40 times greater than heroin, illicitly manufactured fentanyl’s lighter weight and volume
allow for easier transportation and distribution than heroin.1 Though initially introduced through
heroin supply chains, evidence suggests illicitly manufactured fentanyl has also penetrated
supply chains for counterfeit pharmaceutical pills and cocaine. 25, 26, 27, 28
While illicitly manufactured fentanyl and heroin have a similar half-life of 3 to 7 hours,
the stronger potency and faster metabolic rate of fentanyl produce a more intense high and
allow the user to abuse it more frequently.1 As a result, fentanyl-related overdose deaths
have increased at an alarming rate. From 2013 to 2015, U.S. drug overdose deaths involving
synthetic opioids other than methadone (a statistical category overwhelmingly dominated by
fentanyl and fentanyl analogs) increased by 209%.25 Evidence suggests these estimates likely
undercount overdose deaths involving synthetic opioids like fentanyl, as approximately one-fifth
of death certificates fail to list any specific drug involved in the fatal overdose.29

Contemporary Local Trends
East Baton Rouge Parish recently began to reflect earlier national trends in opioid
prescribing patterns, as well as opioid-related morbidity and mortality. From 2016 to 2019, the
number of opioid prescriptions issued to patients residing within East Baton Rouge Parish
decreased by approximately 22% (see Figure 1).
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FIGURE 1. PRESCRIPTIONS ISSUED BY PATIENT RESIDENCE
EAST BATON ROUGE, 2016-2019
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In addition to the declining number of opioid prescriptions, the potencies of opioid
prescriptions issued to East Baton Rouge Parish residents have substantially decreased over
the past 4 years. On average, the morphine milligram equivalent of opioid prescriptions issued
to East Baton Rouge Parish residents decreased by approximately 33% from 2016 to 2019 (see
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850
800
750
700
650
600
550
500
450
400
350
300
250
200
150
100
50
0

FIGURE 2. AVERAGE MORPHINE MILLIGRAM EQUIVALENT (MME)
PER OPIOID PRESCRIPTION
EAST BATON ROUGE, 2016-2019

2016

2017

2018

2019

The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020

8

Despite the decline in the amount and potency of opioid prescriptions issued to East
Baton Rouge Parish residents over the past 4 years, opioid poisoning-related emergency
department visits in East Baton Rouge Parish have substantially increased. From 2014 to 2018,
opioid poisoning-related emergency department visits increased by approximately 45% (see
Figure 3). During this 5-year period, heroin poisoning-related emergency department visits
increased by approximately 30%. Even more disturbing, non-heroin opioid poisoning-related
emergency department visits increased by 59%.

FIGURE 3. OPIOID POISONING-RELATED EMERGENCY
DEPARTMENT VISITS
EAST BATON ROUGE, 2016-2019
500
450
400
350
300
250
200
150
100
50
0

2014
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Non-Heroin Poisoning-Related Visits

2017

2018

Heroin Poisoning-Related Visits

Note: 2019 data were not available for opioid poisoning-related ED visits.
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Reflective of national trends, East Baton Rouge Parish opioid-related overdose deaths
from 2018 to 2019 disproportionately occurred among individuals who were white (72%) and
male (67%). During this time period, the majority of individuals who died of opioid overdose
were between 30 and 44 years old (67%). Rapid increases in opioid overdose deaths remain
a cause for concern. From 2018 to 2019, opioid overdose deaths in East Baton Rouge Parish
increased by approximately 29% (see Figure 4). Opioid overdose deaths have consistently
accounted for nearly all overdose deaths in East Baton Rouge Parish during this time frame.
Though 2020 data are not included in the figures of this report, as they are incomplete and
cannot yet be compared to 2018 — 2019 data, it is worth noting the continued steep rise of
overdose deaths in East Baton Rouge Parish. Alarmingly, opioid overdose deaths between
January to June 2020 increased by 113% compared to the same months the year before. By
August 2020, East Baton Rouge Parish experienced more opioid overdose deaths than in all of
2019. These data necessitate further action to reduce the impacts of opioid misuse within the
community.
FIGURE 4. OVERDOSE DEATH TRENDS
EAST BATON ROUGE, 2018-2019
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BEST PRACTICES FOR OPIOID OVERDOSE PREVENTION AND
THE ROLE OF CRIMINAL JUSTICE PARTNERSHIPS
IPS EFFORTS

Criminal justice practitioners (e.g., law enforcement, correctional officials, defense attorneys,
prosecutors, court officials) have an important role in reducing opioid-related addiction,
overdose deaths, and violence within East Baton Rouge Parish communities. Individuals with
substance use disorder are often fearful of interacting with law enforcement due to the belief
that they will be arrested for their addiction, decreasing the likelihood that these individuals
will reach out for critical treatment. Therefore, public health officials can be reluctant to include
criminal justice practitioners in substance use disorder reduction efforts, despite their ability to
engage in meaningful, productive partnerships. For these perceptions to change, criminal justice
practitioners must demonstrate a commitment to addiction and overdose prevention by forming
vital partnerships and supporting their partners’ prevention efforts to address this epidemic.
In October of 2018, the Office of the District Attorney for the 19th Judicial District in East
Baton Rouge was awarded the IPS grant by the U.S. Department of Justice, Office of Justice
Programs, Bureau of Justice Assistance. The goal of the IPS grant is to reduce opioid-related
deaths by fostering inter-agency collaboration to disrupt local opioid supply chains, educate the
community about the dangers of opioid abuse and addiction, and provide support for individuals
with opioid use disorder. The current agencies involved in the IPS partnership are listed in the
Appendix. The following sections describe IPS approaches and activities to address opioid
overdose prevention.

Overdose Death Response and Investigation Protocols
The IPS grant recognizes that arresting users and individuals with substance use
disorders will not improve our community’s addiction problem. Instead, an emphasis should
be placed on identifying the suppliers that have worsened and exacerbated the problem. Law
enforcement should implement consistent overdose death investigation protocols that treat
every overdose death scene as a potential homicide (rather than dismiss overdose deaths as
a victim-less crime), allowing for a thorough investigation with an emphasis on the retention
and preservation of evidence. Doing so enhances overdose investigations and supports future

11

Social Research & Evaluation Center, Louisiana State University

prosecutions. Responding officers should be cognizant of the unique forms of evidence critical
to successful prosecution, specifically the collection and forensic extraction of data from mobile
devices. Furthermore, officers should be mindful of the need to work in a cooperative and
coordinated effort with the coroner’s office at the scene.

Enhance Use of Data Tools in Law Enforcement
Understanding the full extent of the opioid epidemic is essential to know which programs
to implement and where to implement them. Officials and leaders must rely on coordination
and information sharing between agencies. The ability to access real-time, pertinent information
through robust surveillance, monitoring, and data analysis can better prepare criminal justice
agencies’ responses. The following details a few examples of the analytical tools and products
proposed by the IPS grant:
Geographic Information System (GIS) Mapping Software allows analysts to draw upon
local data to understand the spatial distribution of narcotic incidents and opioid overdose
fatalities throughout a specific geographic region. Descriptive spatial analyses can be used to
develop maps delineating areas with the greatest need for attention and assistance. Inferential
spatial analyses can be used to find factors associated with geographic patterns in incidences
or fatalities, and to generate maps that forecast vulnerable areas. Employing these techniques
offers the opportunity for criminal justice agencies to proactively address the opioid epidemic
by identifying locations for tailored crime reduction, community policing, and harm reduction
strategies.
Figures 5 – 10 are examples of GIS maps detailing data trends that criminal justice
agencies can use to understand the full scope of the opioid epidemic within local communities.
These maps used data from IPS partners to highlight the areas experiencing the greatest
problems and needs. Many of these maps illustrate the interrelated issues of the complicated
and changing nature of overdoses over time.
Figures 5 – 8 illustrate the increase and spread of opioid overdoses across East Baton
Rouge Parish from 2018 to 2019, according to emergency medical service (EMS) records and
911 calls. Figures 9 and 10 illustrate the decrease in opioid prescriptions per parish resident from
2018 to 2019.

The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020
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FIGURE 5. COMPUTER-AIDED DISPATCH (CAD) CALLS WITH (POSSIBLE) OVERDOSE,
EAST BATON ROUGE PARISH, 2018

Kernel Density

Note: Records include all CAD
calls indicating overdose deaths
and possible overdose deaths.
Source: SREC Database;
Map by G. Richardson

				
		

FIGURE 6. COMPUTER-AIDED DISPATCH (CAD) CALLS WITH (POSSIBLE) OVERDOSE
EAST BATON ROUGE PARISH, 2019

Kernel Density

Note: Records include all CAD
calls indicating overdose deaths
and possible overdose deaths.
Source: SREC Database;
Map by G. Richardson
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FIGURE 7. EMS OPIOID IMPRESSIONS (OVERDOSE DEATHS ), EAST BATON ROUGE PARISH, 2018

Opioid Impressions
per Zip Code

Note: Total number of opioid
impressions Jan-Dec 2018 (1806)
Source: SREC Database;
Map by G. Richardson

FIGURE 8. EMS OPIOID IMPRESSIONS (OVERDOSE DEATHS). EAST BATON ROUGE PARISH, 2019

Opioid Impressions
per Zip Code

Note: Total number of opioid
impressions Jan-Dec 2019 (1844)
Source: SREC Database;
Map by G. Richardson
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FIGURE 9. OPIOIDS BY PATIENT (MME PER PRESCRIPTION) PER ZIP CODE
EAST BATON ROUGE PARISH, 2018 (YEARLY AVG.)

Opioids by Patient
MME/Prescription

Note: MME is Morphine Milligram Equivalent;
MME per opioid prescriptions by “patient”
location (zip code). Using the AHFS
Classification, Opiate Agonists and Antitussive
were selected and then filtered to include only
opioids. Opioid Partial Agonists (ie.
Suboxone, Buprenorphine, etc.) were not
included, n/a = removed zip code(s) in
compliance with state law regarding deidentified information. SREC Database;
Map by G. Richardson

FIGURE 10. OPIOIDS BY PATIENT (MME PER PRESCRIPTION) PER ZIP CODE
EAST BATON ROUGE PARISH, 2019 (YEARLY AVG.)

Opioids by Patient
MME/Prescription

Note: MME is Morphine Milligram Equivalent;
MME per opioid prescriptions by “patient”
location (zip code). Using the AHFS
Classification, Opiate Agonists and Antitussive
were selected and then filtered to include only
opioids. Opioid Partial Agonists (ie.
Suboxone, Buprenorphine, etc.) were not
included, n/a = removed zip code(s) in
compliance with state law regarding deidentified information. SREC Database;
Map by G. Richardson
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Social Network Analysis encompasses a multitude of analytical techniques that describe
the social relationships (if any) among actors involved in law enforcement narcotic incidents.
These techniques help identify ties among individuals involved in the manufacturing, supply,
and distribution of illicit opioids, as well as individuals with ties to victims of overdose and
drug-related homicides. Using these techniques to develop social network maps provides an
illustration of the illicit drug market structure and allows law enforcement to prioritize which
suspects would be most beneficial to engage. This approach provides valuable insight into
distribution supply chains operating within East Baton Rouge Parish, identifies key actors
associated with each distribution access point, and potentially allows law enforcement to disrupt
the network. By working with data analysts to develop these products, law enforcement can
more efficiently distribute agency resources for investigation and enforcement operations.
Uniform Device Forensic Extraction Techniques use proprietary technology to locate,
access, and extract data stored within cellphones and mobile devices (e.g., geolocation data,
communication logs, social media information). These techniques may only be used under
justifiable, ethical conditions with the issuance of a judicial warrant to execute a search of
mobile devices. Using mobile device forensic extraction techniques, law enforcement can
rapidly obtain information at the scene of an overdose death, which may provide useful to
multiple investigations. Archived data on mobile devices may be used to trace illicit opioid
suppliers via phone calls and text messages, as well as public and private interactions through
social media applications. This information helps investigators understand illicit drug markets
by providing historical transaction patterns and critical evidence for prosecution efforts against
manufacturers, distributors, and suppliers. For this technique to be useful, law enforcement
needs adequate staffing with proper training and expertise in using uniform device forensic
extraction technology to perform forensic analysis and develop timely reports to enhance
investigatory and prosecution capacity.

Educate the Community on the Dangers of Opioids and Opioid Addiction
Beyond simply disrupting illicit opioid supply chains, criminal justice agencies have
several important roles in reducing the demand for illicit opioids within local communities. These
roles include, but are not limited to:
•
•
•
•

Enhancing public awareness regarding the opioid epidemic;
Educating local communities about opioid abuse and addiction;
Participating in programs that reduce the availability of unused prescription opioids within
local communities; and
Identifying potential individuals to link with appropriate treatment programs and care
facilities.

The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020
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The following information outlines the various strategies employed by the IPS grant to
engage with each role.
Public Relations Campaign
IPS grantees and partners developed a public relations campaign via radio, social media,
and a web page targeting the populations most susceptible to opioid overdose fatalities within
East Baton Rouge Parish. The campaign aimed to increase awareness of the opioid epidemic
and patterns of addiction, and to provide information on how to reduce opioid exposure within
their communities.
Community Forums
To increase community awareness of the opioid epidemic, IPS grantees and partners
are planning to host a series of community forums presenting data about the drastic increase in
opioid abuse and opioid overdose fatalities in East Baton Rouge Parish, as well as educational
material detailing the risks of opioid addiction and methods to prevent opioid abuse. Through
these community forums, partners will share information about the safe use and disposal of
prescription opioids through the means of medication drop box locations or DEA Take Back Day
programs. They will also share resources concerning community treatment options, including
how to identify and enroll in appropriate treatment programs. In addition, partners will also offer
information about naloxone distribution sites and training programs.
Push cards
IPS grantees and partners are developing informational cards containing relevant
overdose resources to distribute among community forum participants, as well as among
survivors, family members, friends, and witnesses at the scene of an opioid overdose. These
cards will provide crucial information in case of an opioid overdose, including instructions
for proper naloxone administration, community treatment resources, and coroner contact
information in the case of an opioid overdose fatality.
The Good Samaritan Law
IPS intends to publicize the Good Samaritan Law as part of community education efforts.
Fear of arrest and prosecution presents a significant barrier to individuals seeking medical
assistance in the event of an overdose. The legal immunities provided by Good Samaritan laws
vary from state to state, ranging from broad immunities that prevent arrest and prosecution, to
partial immunities.
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In general, Good Samaritan laws may provide a degree of medical amnesty for:
•
•
•
•

Individuals seeking medical attention for another individual experiencing a drug-related
overdose;
Individuals experiencing a drug-related overdose;
Bystanders in possession of drugs or drug paraphernalia; and
Medical providers who prescribe or administer opioid reversal medication.

Currently, the Louisiana Good Samaritan laws provide immunity to individuals who
need medical assistance for a drug-related overdose. Specifically, the immunity applies to
charges, prosecution, or penalties for possession of a controlled dangerous substance, as
defined by the Uniform Controlled Dangerous Substance Law, if evidence was obtained as
a result of the overdose and call for medical assistance (La. Rev. Stat. Ann. § 14:403.10).30
These protections extend to individuals acting in good faith who seek medical assistance for
an individual experiencing a drug-related overdose, so long as this person did not illegally
provide or administer the controlled dangerous substance.31 Although these provisions prevent
individuals from being prosecuted and sentenced, these individuals are not shielded from arrest
for possession of a controlled dangerous substance. Additionally, the Louisiana Good Samaritan
laws provide immunity from criminal and civil liability to medical providers who prescribe
naloxone, pharmacists who dispense naloxone, and any individual who administers naloxone to
a person believed to be experiencing an opioid-related overdose (La. Rev. Stat § 40:978.2).32
Though evidence suggests Good Samaritan laws reduce overdose fatalities, the laws
are only effective if the general public and those most susceptible to drug-related overdose
are aware of their existence.31 To our knowledge, no study has been conducted in East Baton
Rouge Parish to examine public awareness of the Louisiana Good Samaritan laws. Push cards
and community forums (especially in “hotspot” neighborhoods) providing education about Good
Samaritan laws and the use and availability of naloxone are two ways to share this information
so that it is publicly known and understood by the community.
DEA Take Back Day
Public education on the importance of safely storing and disposing prescription
pain medication, and giving them the ability to do so, reduces access to opioids within the
community. Twice per year, the Drug Enforcement Administration (DEA), an active partner of
the IPS grant, hosts national and local Take Back Day events to encourage citizens to bring
unused and expired medication to predetermined locations for proper disposal. Criminal justice
agencies can actively participate in these events by encouraging public participation, as well
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as hosting drug disposal boxes for continuous disposal of unused or expired opioids and other
types of medication.
Prescription Monitoring Program (PMP)
As an active partner of the IPS grant, the Louisiana Board of Pharmacy provides data
from the Prescription Monitoring Program (PMP) to describe opioid prescribing patterns.
Ensuring prescribers receive proper training and education, as well as access to use the PMP
portal, protects patients and physicians from the dangers associated with over-prescribing.
Louisiana law requires prescribers to consult the PMP portal to review and monitor each
patient’s opioid prescription history prior to and during treatment, with some exceptions (La. Rev.
Stat. § 40:978).32 Prescribers should be encouraged to comply with the PMP, as the database
serves as an important tool to prevent doctor shopping and the over-prescribing of opioids and
other addictive substances.33
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BEST PRACTICES FOR OPIOID OVERDOSE PREVENTION AND
THE ROLE OF CRIMINAL JUSTICE PARTNERSHIPS
CRIMINAL JUSTICE PRACTICES
The following criminal justice programs have shown effectiveness for individuals experiencing
opioid use disorder. Some programs are already being implemented to some extent in East
Baton Rouge Parish, while some have not yet been considered.

Drug Courts – Diversion and Reentry
Drug courts (i.e., specialized courts designed to handle non-violent offenders with
substance use disorders) combine substance use treatment with the legal and moral authority of
the court to disrupt the cycle of substance use and drug-related crime.34, 35, 36, 37 Implemented
for pre- and post-adjudication efforts, drug courts provide candidates with a series of
requirements to be completed in exchange for: a) reduced or dismissed charges; b) release on
condition of probation; or c) release on condition of parole.36 Upon referral and screening for
program eligibility, candidates who agree to participate are expected to abide by various court
mandates, which consist of regular appearance before the court for status hearings, as well as
adherence to a comprehensive treatment regimen addressing substance use, mental health,
education, and employment.36, 37, 38, 39, 40
Since drug court programs are multiphasic, status hearings provide an essential forum for
judges and various court staff to engage with participants about their individualized treatment
plans and progress.36, 37 By implementing the principle of graduated sanctioning and rewards,
the authority of the court is used to motivate program compliance.36, 39, 41 Participants who
adhere to the court mandates advance through three or more progressively less intense phases
before completing the program, culminating in a formal graduation ceremony upon successful
completion of drug court.37, 39 Participants who fail to adhere to the court mandates are
gradually sanctioned with each subsequent failure to comply. 37, 39 As a last resort, participants
who fail to adhere to court mandates may be dismissed from the program and incarcerated. 37,
39, 40

Pre-adjudication drug courts emphasizing diversion typically have a 6- to 12-month
duration. In contrast, post-adjudication drug courts focusing on community reentry are longer-
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term, lasting upwards of 12 months.37 Evidence suggests drug court programs that last between
8 to 16 months provide the best outcomes regarding recidivism.42, 43 Programs may face
challenges regarding recruitment and retention fo appropriate participants due to the length
and difficulty of this process. Though drug courts may vary in terms of programmatic guidelines,
the key components of drug courts are:
•
•
•
•
•
•

Collaborative, non-adversarial, outcome driven court processing;
Early identification of eligible participants;
Substance use treatment integrated with criminal justice case processing;
Frequent urinary analyses;
Judicial monitoring; and
Implementation of graduated sanctioning and rewards.35, 36, 39

Evidence suggests adult drug courts significantly reduce the likelihood of three-year recidivism
for general offenses and drug-related offenses.37 Conversely, juvenile drug courts have
been demonstrated to significantly reduce the likelihood of three-year recidivism for general
offenses.37

Pre-Release and Post-Release Treatment Services
Drug overdose is the leading cause of death among formerly incarcerated individuals
in the initial two years following release.44 Relative to the general population, formerly
incarcerated individuals exhibit higher rates of fatal overdose, experiencing a 3- to 8-fold
increase in the risk of opioid-related mortality within the first 2 weeks of release, which is
sustained throughout the first month of community reentry.44, 45 It is imperative to consider
the roles of pre-release and post-release treatment services within the continuum of care for
incarcerated individuals.46
Pre-release treatment services (i.e., substance use treatment services delivered
throughout a term of incarceration) offer a prime opportunity to engage opioid-dependent
incarcerated individuals with sustainable recovery options that can continue upon release.47, 48
Though a variety of programs exist, a substantial amount of evidence suggests implementing
the following three interventions during incarceration effectively reduces subsequent substance
use and recidivism:
•
•
•

Cognitive behavioral therapy;
Therapeutic communities; and
Medication-assisted treatment (MAT).47, 49
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Each program exists within correctional and community settings, allowing law enforcement
to collaborate with local service providers prior to an individual’s release to establish a postrelease treatment plan that ensures continual access to care.47
Post-release services focus on continuing and expanding treatments that were initiated
during incarceration, and address negative outcomes in the weeks following release. One
example is Prison Take-Home Naloxone programs, which provide naloxone training and devices
to individuals at the time of release to help reduce overdose deaths. These programs have high
participation rates among individuals with a history of injection drug use,50 and are associated
with a 36% reduction in drug overdose deaths in the first four weeks post-release from prison.51
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BEST PRACTICES FOR OPIOID OVERDOSE PREVENTION AND
THE ROLE OF CRIMINAL JUSTICE PARTNERSHIPS
PUBLIC HEALTH PRACTICES
The following describes practices and programs implemented in the wider community that
would benefit from the participation and support of criminal justice practitioners. Each of these
practices require community partnerships to reduce recidivism, overdose deaths, and other
negative individual and societal consequences of opioid misuse.

Harm reduction
Harm reduction strategies are important components for comprehensive interventions
which mitigate the negative health consequences of opioid misuse and opioid use disorder.
Implemented before and during treatment, these strategies reduce physical harm and mortality
by integrating education with a linkage to resources.
Through the Louisiana State Opioid Response (LaSOR) federal grant, Capital Area Human
Services (CAHS) in Baton Rouge launched an Opioid Mobile Outreach Team and a mobile
crisis unit in early 2020 which travels among opioid overdose hot spots to provide addiction
counseling, medication-assisted treatment, naloxone distribution, laboratory testing, and needle
exchange services.52 This section describes the importance of law enforcement and community
support to sustain and expand these harm reduction efforts.
On scene use of naloxone and other medications to reverse overdose
Naloxone (Narcan, Evzio) is an FDA-approved medication used to block or reverse the
effects of an opioid overdose quickly and safely, thereby preventing overdose fatalities. There is
no potential for addiction or abuse of the medication. Naloxone can be used without harm to the
victim of the overdose even if the cause of the overdose is unknown. If it is available, naloxone
can be administered immediately to the overdose victim at the time and place of the overdose.
Education efforts are needed along with naloxone dosing as emergency medical care is usually
also required. Making naloxone available to heroin users has not been shown to increase drug
use.53
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Empirical evidence establishes naloxone distribution as an effective intervention for
preventing opioid overdose deaths.54 Naloxone must be administered promptly once overdose
occurs to be effective. Therefore, it is essential to provide naloxone and training on its use to
bystanders and first responders, including firefighters and police officers who may arrive on
scene before paramedics. In 2018, the U.S. Surgeon General55 released an advisory for the
following groups to have naloxone within reach and know how to administer it:
•
•
•
•
•

First responders including paramedics, police officers, and fire fighters;
Patients prescribed a high dose of opioids for pain management;
Individuals misusing opioids, including prescription opioids and illicit opioids (e.g., heroin
or fentanyl);
Family and friends of individuals with opioid use disorder; and
Healthcare providers.
Other communities and states have successfully prevented opioid overdoses by

providing naloxone and training first responders and non-medical bystanders.56 Training
includes the signs of overdose and how to administer naloxone, as well as the importance for
bystanders to call 911 as soon as they recognize an overdose is occurring. SAMHSA57 published
the Opioid Overdose Prevention Toolkit, which is publicly available on their website, for
prescribers, community members, patients recovering from opioid use disorder, and the families
of individuals with opioid use disorder. The toolkit can be used by health trainers to educate
about opioids and how to prevent overdose, recognize overdose, and administer naloxone. The
toolkit also discusses strategies for community and local governments to prevent opioid deaths,
including ensuring that naloxone is readily available.
Naloxone can be administered by injection or intranasally. EVZIO® is an auto-injectable
device pre-filled with a dose of naloxone and can be purchased without a prescription.58
However, it is costly at $4,100. The nasal spray, NARCAN®, comes in a kit which includes two
doses. Narcan kits cost an average of $140 each without insurance, though this may be lower
for law enforcement.59 Generic naloxone averages around $40 per dose. Prescription coverage
of naloxone varies depending on the diagnosis and an individual’s medical coverage. Therefore,
it is important to bring in community partners to ensure resources are provided to both first
responders and those at-risk of overdose to obtain naloxone.
Leave Behind Naloxone Program
Individuals who have experienced an overdose are at risk for another overdose incident.
Expanding upon the naloxone administration by bystanders, another best practice includes
leaving behind a naloxone kit with at least one dose and instructions for use with someone who
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has overdosed or a loved one.59 These interventions commonly use a combination of training
EMS to teach patients and families how to use naloxone kits that they “leave behind” and link
patients to substance use treatment. Other similar models, called “take home” programs, entail
the provision of naloxone and training to overdose victims and family members by emergency
department staff.60
Needle and syringe exchange programs
The rise in opioid addiction and subsequent increase in injection drug use has been
linked to increases in Hepatitis C infections in the U.S.,60 as well as community outbreaks of
HIV.61, 62 The U.S. Surgeon General55 and the American Medical Association63 recommend
that needle exchange programs be established in all communities. These programs generally
provide clean needles and safe disposal of used needles, as well as lab testing for HIV and
Hepatitis C, health education, linkage to substance use treatment, mental health and medical
services, and social services.64 Needle exchange and syringe exchange programs have been
shown to be effective in reducing the transmission of infectious diseases (such as Hepatitis C
and HIV) resulting from sharing needles, as well as serving as a bridge to addiction treatment.65,
66

Moreover, injection drug users who participate in these types of programs are more likely to

seek treatment than those who do not participate.65
In 2017, Louisiana legalized syringe exchange programs but allowed individual
communities to decide whether these programs should be made available to residents in
their parishes.67 That same year, the East Baton Rouge Metropolitan Council changed a parish
ordinance in order to allow needle and syringe exchange programs for its residents. New
Orleans, Alexandria, and Shreveport have passed similar ordinances.67, 68
Fentanyl testing kits
The dramatic rise of overdose deaths in the U.S. since 2015 has been attributed to the
illegal manufacturing and use of the synthetic opioid fentanyl, which is mixed with heroin and
other drugs such as cocaine to increase its potency.69 A person who buys illicit drugs has no
way of knowing by looking at the drug whether it contains fentanyl and if so, how much, thus
also leaving the person unaware of the odds of overdose.
Fentanyl Test Strips (FTS) have increasing popularity in community harm reduction
programs. They work by diluting a small amount of drug with water and dipping a test strip into
the mixture.70 Within a few minutes, an indicator on the test strip appears if fentanyl is detected.
The strips are inexpensive and highly accurate. While the evidence of their overall efficacy is still
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limited, studies show that there is a willingness among people who inject drugs to use FTS to
inform behaviors that prevent overdose.71, 72

Treatment and Recovery Support
Expanding access points to screening, referral, and treatment
Timely screening, referral, and treatment are important factors in decreasing deaths from
opioid overdose for those with opioid use disorder. While post-release programs are essential,
not all who need addiction services encounter the criminal justice system. Criminal justice
practitioners and their community partners (Emergency Medical Services, hospital emergency
departments, treatment providers, primary care and specialty physicians and prescribers, dental
and allied health professionals, and concerned community members) can work together to
link potential candidates to treatment. Each of these partners represent a possible access point
to a person with addiction. Ensuring the provision of appropriate screening for opioid misuse,
resources, and referral to treatment at multiple access points expands outreach to a broader
population more frequently.
An important group to include in this effort are first responders who are often repeatedly
sent to the same addresses and administer naloxone to the same individuals. These first
responders have first-hand knowledge of who could benefit from treatment in our community.
This knowledge makes our first responders an excellent referral source to treatment in the
community.
Community-based Medication-Assisted Treatment (MAT)
Due to the nature of drug dependence and its lasting effects on the brain, addiction
should be considered and treated as a chronic medical illness.73 The complex causes and
effects of addiction, including genetics and environment, require multi-modal, long-term
strategies to achieve treatment retention. Medication-Assisted Treatment (MAT) involves the
use of medications such as methadone, buprenorphine, or extended-release naltrexone. MAT
is effective in treating both prescription opioid and heroin addiction. MAT is associated with
higher retention rates, especially when combined with behavioral therapy.74 Community-based
MAT uses medication in combination with counseling and behavioral therapies to provide a
“whole-patient” approach to the treatment of substance use disorders.75 Research shows that a
combination of medication and behavioral therapy can successfully help individuals struggling
with addiction sustain recovery.76, 77
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Despite its effectiveness, MAT has been slow to expand due to a long-standing
preference for outdated models of abstinence-only treatment. It was only in 2019 that Capital
Area Human Services (CAHS) began to offer MAT for individuals with opioid use disorder.52
Due to the scarcity of MAT providers, many individuals seeking treatment face the possibility
of traveling long distances to access their provider, which could greatly affect retention.78
Therefore, other settings such as primary care clinics, Federally Qualified Health Centers, and
mobile units have begun to provide MAT to individuals in their own communities. Studies show
that primary care clinics can be effective in providing MAT for maintenance treatment.78 The
LaSOR grant began to offer MAT to East Baton Rouge residents through its mobile unit in early
2020.52
Peer recovery programs
Peer recovery support programs use a continuum of care, chronic illness approach
to recovery,79 and provide a bridge between the previously mentioned points of access and
treatment. They are implemented by Peer Recovery Support Specialists (PRSS), individuals who
have experienced addiction and recovery and are trained to offer various forms of peer support
to individuals with addiction. PRSSs perform an array of services, including education on and
provision of naloxone; referrals to medical treatment, addiction treatment, needle exchange
programs, and community services (including housing, food, and employment resources);
assistance with accessing resources and treatment; support in developing personalized
recovery plans and goal setting; and non-clinical emotional support from the perspective of
someone who has experienced addiction and the recovery process.79, 80 Peer recovery support
programs are most effective when PRSSs are well-trained and their involvement is integrated
across each stage of recovery, from pre-engagement into treatment through recovery
maintenance.80, 81, 82
Organizations and communities have successfully implemented peer-based support
programs in a variety of settings where individuals with drug use disorders are already engaged:
hospital emergency departments, community outreach programs, recovery centers, drug courts,
prisons, parole and probation programs, churches, sober living and recovery support homes,
and addiction treatment centers. 79

Other Community-Based Programs
Public Health and Safety Teams (PHAST)
The Public Health and Safety Team (PHAST) program uses a public health and public
safety partnership approach. The program conducts overdose fatality reviews with multi27
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agency partners. These partners identify changes and plans for targeted responses and
actions that can prevent future overdoses. The PHAST partners make recommendations
to reduce barriers for agencies to implement changes, help meet the needs for addiction/
overdose problems, and related issues. The decision makers in these agencies can leverage
connections and relationships to make appropriate changes and support implementation of
the recommendations. The PHAST partners generally consist of community, public health,
and public safety agencies. A team of those responsible for the day-to-day agency activities
generally make recommendations for an administration-level (i.e., sheriff, hospital administrator,
District Attorney) team to implement.
The CDC’s PHAST Toolkit Version 2.0 was released in March 2020 for download and
dissemination. While there is no empirical evidence of the PHAST model’s impact on reducing
overdoses, overdose fatality reviews are growing in popularity and are increasingly being used
across the country.
Overdose Detection Mapping Application Program (ODMap)
ODMap is a mapping surveillance application tool that can be used to detect spikes
and locations of overdoses in real-time in the community and shared across jurisdictions using
the application. First responders enter data from the scene of overdoses that are mapped and
shared with public health and public safety officials. By quickly identifying overdose hot spots,
officials can quickly alert the public, identify the source of the overdoses, and coordinate and
deploy harm reduction resources to prevent more overdoses.
In Rhode Island, the AnchorMORE program is able to use surveillance data to target
the deployment of several programs mentioned in this document, including Peer Recovery
Specialist teams, naloxone distribution and education, and referral services to resources and
addiction treatment.79 Specifically, AnchorMORE used data surveillance of opioid deaths to
determine how many naloxone kits should be distributed in each town.
When known, drug suppliers causing fatal overdoses are an important source of
public health information that should be shared with the dealers’ other contacts and buyers
of the potential deadly batch. While not using the ODMap application, specifically, mapping
surveillance was shown to be an effective tool for the deployment of resources when the
location of overdose hot spots was known to public officials in real-time. The ODMap application
information and program implementation training manuals are available at ODMap.org.
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RECOMMENDATIONS FOR FUTURE ACTION
This report highlighted national and local trends concerning the opioid epidemic, as well as
detailing IPS proposals for innovative criminal justice efforts. Though the proposed measures
provide an important foundation, a review of contemporary evidence-based practices suggests
that additional actions are required to comprehensively address opioid-related overdoses and
violence. The following recommendations and action items should be considered by criminal
justice practitioners regarding intervention development and implementation.

Recommendation: Implement Departmental Protocols Regarding
Possession and Use
Departmental protocols should be implemented concerning discretionary law enforcement
responses to the possession and use of illicit opioids. Rather than arresting individuals solely
for small amounts of drugs and drug paraphernalia indicative of personal use, departmental
protocols should emphasize linking individuals to community programs (such as Peer Support
Specialists) and obtaining cooperation which would enhance the ability to pursue those
responsible for manufacturing, supplying, and distributing illegal narcotics in the community.

Recommendation: Continue to Utilize Federal Law Enforcement Levers
Criminal justice agencies should continue to leverage federal law enforcement partnerships to
access the investigatory and prosecutorial resources available to East Baton Rouge Parish as a
High Intensity Drug Trafficking Area (HIDTA) to pursue cases involving manufacturers, suppliers,
and distributors.

Recommendation: Identify and Monitor Social Networks Using
Social Media Data
Criminal justice agencies should use data scraping techniques and social network analysis to
identify patterns of illicit drug sales occurring on public social media. This information can assist
law enforcement in understanding the structure of local illicit drug networks, as well as form the
basis of actionable intelligence.

29

Social Research & Evaluation Center, Louisiana State University

Recommendation: Develop a Forensic Certification-Based
Collegiate Internship
Criminal justice agencies should develop a collegiate internship program in which law
enforcement provide local college students with the necessary training to receive a uniform
forensic analyst certification (e.g., Cellbrite Analyst Certification), as well as professional
experience utilizing this training within a Crime Strategies Unit or local law enforcement
agency. Though training and certification costs would be associated with the implementation,
this program would be mutually beneficial to criminal justice agencies and collegiate interns.
This program would enhance the investigatory and prosecutorial capacities of criminal justice
agencies by aiding in the extraction, analysis, and reporting of data acquired from mobile
devices, while providing interns with valuable training and experience which can assist them
with future employment.

Recommendation: Provide Appropriate Referrals to Drug Court
IPS partners should refer potential participants to the District Attorney for the 19th JDC Drug
Court treatment and diversion program. Through calls for overdose assistance, law enforcement
and first responders are informed referral sources for individuals suffering from substance use
disorders who can benefit from the services provided by the diversion process.

Recommendation: Establish a Prison Take Home Naloxone Program
Parish and state correctional facilities should distribute naloxone upon release to individuals
who have a history of substance use disorder, overdose, or charges pertaining to drug use, as
well as provide training on proper naloxone administration, to reduce overdose deaths after
release. This is recommended if it is allowable by the State of Louisiana’s Standing Order for the
Distribution or Dispensing of Naloxone or Other Opioid Antagonists according to LA Rev Stat §
40:978.283 or any other applicable statute.

Recommendation: Establish a Leave Behind Naloxone Program
Criminal justice agencies should collaborate with public health and community organizations to
establish a naloxone leave behind program for first responders. At sites of overdose survival,
first responders should be prepared to leave naloxone with the survivor of an overdose or
individuals in a position to assist the survivor, as well as provide training on proper naloxone
administration. This is recommended if it is allowable by the State of Louisiana’s Standing Order

for the Distribution or Dispensing of Naloxone or Other Opioid Antagonists according to LA Rev
Stat § 40:978.283 or any other applicable statute.
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Recommendation: Provide Insight Regarding Overdose Hotspots
Criminal justice agencies should partner with public health officials to share relevant data
about the location of overdoses and the concentration of hotspots to inform the deployment of
resources (e.g., Louisiana State Opioid Response Medication-Assisted Treatment Mobile Unit)
and prevention specialists.

Recommendation: Implement a Public Health and Safety Team (PHAST)
Criminal justice agencies should partner with public health and community organizations to
implement a Public Health and Safety Team (PHAST) responsible for conducting overdose
fatality reviews. This practice will enable better coordination and development of strategies to
allocate resources and services to prevent future overdoses.

Recommendation: Strengthen Community Partnerships to Expand
Access Points
Criminal justice agencies should partner with public health and community organizations to
implement protocols which support prevention efforts, community-based treatment, harm
reduction, and recovery efforts. As first responders, criminal justice practitioners should
emphasize connecting individuals with substance use disorders to viable treatment programs,
removing existing barriers to adequate treatment and recovery, and reserving incarceration
as a last resort. Furthermore, criminal justice agencies should join community-based treatment
providers, advocating for adequate resources required to meet treatment demands.

Recommendation: Expand Prescription Medication Disposal Programs
Criminal justice agencies should engage in community partnerships to expand prescription
medication disposal programs by permanently establishing secure disposal sites for unused and
expired medication at law enforcement substations and other amenable community locations.
By expanding administrative disposal protocols and participating in community events to raise
awareness of proper prescription medication disposal, criminal justice agencies can reduce
prescription opioid abuse within local communities.
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Recommendation: Expand Community Education Efforts
IPS partners should expand planned community education efforts, such as push cards and
community forums, to include information about situation-specific support programs for
survivors (e.g., pregnancy-based treatment, neonatal treatment, safe needle exchange sites).
Information about Medicaid and other public assistance treatment opportunities should be
readily available.

Recommendation: Support the Expansion of Treatment and
Harm Reduction Efforts
IPS partners should support effective harm reduction efforts, such as needle exchange
programs, Take Home Naloxone programs for hospitals, fentanyl testing kits, as well as
community-wide access to evidence-based treatments such as MAT and peer-recovery
programs.

Recommendation: Publicize the Good Samaritan Laws
Criminal justice agencies should partner with public health and community organizations to
raise public awareness of the current Good Samaritan laws, including situational limitations for
immunity.

Recommendation: Bolster Prevention Efforts
The IPS inter-agency partners, communities, schools, and public health agencies should
develop cross sector partnerships to prevent the development of substance misuse among
youth and other vulnerable populations. Prevention efforts among partners should be
highlighted in public awareness and educational campaigns.
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APPENDIX

IPS Partner Agencies
Baton Rouge Police Department
Drug Enforcement Administration
East Baton Rouge Parish Coroner’s Office
East Baton Rouge Parish District Attorney’s Office
East Baton Rouge Parish District Attorney’s Office - Crime Strategies Unit
East Baton Rouge Parish Emergency Medical Services
East Baton Rouge Sheriff’s Office
Louisiana Board of Pharmacy - Prescription Monitoring Board
Louisiana Department of Corrections - Probation/Parole
Louisiana State University
US Attorney’s Office
US Postal Inspector
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